Startseite Comparison of Tissue Polypeptide Antigen (TPA) with Cancer Antigen 15-3 (CA 15-3) and Carcino-embryonic Antigen (CEA) in Follow-up of Breast Cancer
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Comparison of Tissue Polypeptide Antigen (TPA) with Cancer Antigen 15-3 (CA 15-3) and Carcino-embryonic Antigen (CEA) in Follow-up of Breast Cancer

  • Rainer Findeisen , Steffen Albrecht , Barbara Richter , Kersten Deutschmann und Wolfgang Distler
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 36 Heft 11

Abstract

Cancer antigen 15–3 (CA 15–3), carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) were measured in 679 sera of breast cancer patients and in 94 sera of women without breast cancer. The tumour markers were determined using immunoluminometric assays (ILMA). The assays are characterised by an inter-assay-imprecision and intra-assay-imprecision <4 %. The breast cancer patients were staged according to the TNM classification stage 0–IV (by UICC) in patient groups with a compatible prognosis. Median and range of each stage were investigated. The cut-off values (95th and 97.5th percentile of control group) of CA 15–3, CEA and TPA were determined; specificity, sensitivity, positive and negative predictive value (PV) and efficiency were investigated for these cut-off's and the receiver operating characteristic (ROC) curves were calculated. The differences between control group and stage 0–3 were shown as non-significant for CA 15–3 and CEA but significant for TPA. Significant differences were found in stage 4 for all three tumour markers. The three tumour markers did not have differences in specificity, positive and negative PV and efficiency. TPA and CA 15–3 demonstrated comparable results in sensitivity and ROC curve analyses. These results were better than those from CEA.

:
Published Online: 2005-06-01
Published in Print: 1998-11-01

Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Expert Systems for the Interpretation of Serum Proteins
  2. Proteome in Perspective
  3. Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours
  4. Comparison of Tissue Polypeptide Antigen (TPA) with Cancer Antigen 15-3 (CA 15-3) and Carcino-embryonic Antigen (CEA) in Follow-up of Breast Cancer
  5. Continuous Analysis in Extracorporeally Circulating Blood - A Rat Model Applying Flow-Through Ion-Selective Electrodes for the Measurement of Ca2+, K+, Na+ and pH
  6. Improved Specificity of a New Direct Assay for Urinary Cortisol: Application in Corticoid Treated Patients
  7. Quantitative Automated Particle-Enhanced Immunonephelometric Assay for the Routinary Measurement of Human Cystatin C
  8. External Quality Assessment of Stat Test Intralaboratory Turnaround Times. Pilot Study from the Members of the Working Group for the Standardization and Promotion of Turnaround Time Control under the Auspices of the Comitato Italiano per la Standardizzazione die Metodi Ematologici e di Laboratorio
  9. Biological Effects of Eleven Combined Oral Contraceptives on Serum Triglycerides, γ-Glutamyltransferase, Alkaline Phosphatase, Bilirubin and other Biochemical Variables
  10. Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease
  11. IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation
  12. Medical Microbiology by C. Mims, J. Playfair, I. Roitt, D. Wakelin and R. Williams
  13. The Scientist as Consultant. Building New Career Opportunities by Carl J. Sindermann and Thomas K. Sawyer
Heruntergeladen am 15.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1998.148/pdf
Button zum nach oben scrollen